Unlocking the Potential of Ancient Enzymes: A Dive into Cutting-edge Therapeutics Development | Sanjay Shukla , CEO, aTyr Pharma Inc. 00:10:00
Exploring the complex world of biotechnology, this interview delves into Atossa Pharma's mission to harness trna synthetase biology for developing innovative therapeutics targeting inflammatory, fibrotic diseases, and cancer, emphasizing a data-driven approach and a vast pipeline of potential treatments.